Annual reports filed by certain Canadian issuers pursuant to Section 15(d) and Rule 15d-4

BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details)

v3.21.1
BUSINESS COMBINATIONS - Disclosure of detailed information about fair value of identifiable assets acquired and liabilities assumed on acquisition date (Details) - CAD ($)
$ in Thousands
Dec. 31, 2019
Mar. 15, 2019
Assets    
Property, plant and equipment $ 1,074  
Intangible assets 996  
Liabilities    
Bank credit (321)  
Bank loan (624)  
Deferred tax (267)  
Goodwill arising on acquisition $ 292  
Adjupharm GmbH ("Adjupharm") [Member]    
Assets    
Cash and cash equivalents   $ 84
Trade and other receivables   70
Inventories   224
Property, plant and equipment   1,074
Intangible assets   996
Total identifiable assets   2,448
Liabilities    
Bank credit   (321)
Trade payables   (84)
Other payables   (44)
Bank loan   (624)
Deferred tax   (267)
Total identifiable liabilities   (1,340)
Total identifiable assets, net   1,108
Goodwill arising on acquisition   292
Total purchase price   $ 1,400